Legislative Research: OK HB3834 | 2020 | Regular Session

Other Sessions

SessionTitle/DescriptionLast Action
2026
Regular Session

(Passed)
Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; effective date.
[HB3834 2026 Detail][HB3834 2026 Text][HB3834 2026 Comments]
2026-05-12
Approved by Governor 05/12/2026
2024
Regular Session

(Introduced - Dead)
Notaries and notarial acts; Notary Practices Act of 2024; effective date.
[HB3834 2024 Detail][HB3834 2024 Text][HB3834 2024 Comments]
2024-02-06
Second Reading referred to Rules
2022
Regular Session

(Introduced - Dead)
Oklahoma Department of Tourism and Recreation; Oklahoma Department of Tourism and Recreation Amendment Act of 2022; effective date.
[HB3834 2022 Detail][HB3834 2022 Text][HB3834 2022 Comments]
2022-02-08
Second Reading referred to Rules
2020
Regular Session

(Introduced - Dead)
Transportation funding; creating the Transportation Funding Reform Act; effective date.
[HB3834 2020 Detail][HB3834 2020 Text][HB3834 2020 Comments]
2020-02-04
Second Reading referred to Rules

References Online

Search PhraseWebNewsFinancialEncylopediaBiography
[Oklahoma HB3834]Google WebGoogle News
[Oklahoma House Rules Committee]Google WebGoogle NewsFollowTheMoney
[Representative Todd Russ OK]Google WebGoogle NewsFollowTheMoneyBallotpediaVoteSmart

Legislative Citation

APA
OK HB3834 | 2020 | Regular Session. (2020, February 04). LegiScan. Retrieved June 06, 2026, from https://legiscan.com/OK/bill/HB3834/2020
MLA
"OK HB3834 | 2020 | Regular Session." LegiScan. LegiScan LLC, 04 Feb. 2020. Web. 06 Jun. 2026. <https://legiscan.com/OK/bill/HB3834/2020>.
Chicago
"OK HB3834 | 2020 | Regular Session." February 04, 2020 LegiScan. Accessed June 06, 2026. https://legiscan.com/OK/bill/HB3834/2020.
Turabian
LegiScan. OK HB3834 | 2020 | Regular Session. 04 February 2020. https://legiscan.com/OK/bill/HB3834/2020 (accessed June 06, 2026).

Oklahoma State Sources


feedback